Literature DB >> 23172721

Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement.

Will T Roberts1, Jitendra Parmar, Thirumaran Rajathurai.   

Abstract

We report the case of a very late erosion of an Amplatzer septal occluder (ASO) device more than 8 years after implant, presenting without signs of cardiac tamponade. To date, this case represents the longest period between ASO device implantation and clinical presentation following erosion. The overall rate of device erosion remains low, and the majority reported so far has occurred early, but clinicians should remain alert to the possibility of very late erosion in patients with ASO devices.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  Amplatzer occluder; Amplatzer occluder device; Amplatzer septal occluder; atrial septal defect; cardiac surgery; device removal; septal occluder; thoracic surgery

Mesh:

Year:  2013        PMID: 23172721     DOI: 10.1002/ccd.24755

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

1.  Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder.

Authors:  Thomas Herren; Michael Schwanda; Michele Genoni; Franz R Eberli
Journal:  Clin Res Cardiol       Date:  2015-02-27       Impact factor: 5.460

2.  Late complications of an atrial septal occluder provoked by anticoagulant therapy.

Authors:  Uyên Châu Nguyên; Bob Weijs; Peter Luyten; Carin Blokzijl; Maarten Witsenburg; Paul G A Volders; Sebastiaan C A M Bekkers
Journal:  J Cardiol Cases       Date:  2017-11-07

3.  Very late erosion of Amplatzer occluder device resulting in Cardiac tamponade after 15 years.

Authors:  Jan-Erik Guelker; Ruben Jansen; Kolja Sievert; Horst Sievert; Stefan Bertog
Journal:  Clin Res Cardiol       Date:  2018-02-26       Impact factor: 5.460

Review 4.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

5.  Validation of a Prescreening Program for Transcatheter Atrial Septal Defect Closure.

Authors:  George T Nicholson; Robert N Vincent; Christopher J Petit; Meredith Roman; Michelle Glanville; Dennis W Kim
Journal:  Pediatr Cardiol       Date:  2015-03-20       Impact factor: 1.655

Review 6.  Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.

Authors:  Michael L O'Byrne; Andrew C Glatz; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

7.  Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder.

Authors:  Norio Tada; Yukiko Mizutani; Takashi Matsumoto; Mie Sakurai; Tatsushi Ootomo
Journal:  Cardiovasc Interv Ther       Date:  2017-01-20

8.  Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.

Authors:  Daniel R Turner; Carl Y Owada; Charlie J Sang; Muhammad Khan; D Scott Lim
Journal:  Circ Cardiovasc Interv       Date:  2017-08       Impact factor: 6.546

Review 9.  What Interventional Cardiologists Are Still Leaving to the Surgeons?

Authors:  Worakan Promphan; Shakeel A Qureshi
Journal:  Front Pediatr       Date:  2016-06-13       Impact factor: 3.418

10.  Aortic erosion occurring in over 5 years after Amplatzer septal Occluder implantation for secundum atrial septal defect: a case report.

Authors:  Yasuko Onakatomi; Toshihide Asou; Yuko Takeda; Hideaki Ueda; Motohiko Goda; Munekata Masuda
Journal:  J Cardiothorac Surg       Date:  2019-09-06       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.